Alph Bingham, Ph.D
Founder and Member, Board of Directors
Dr. Bingham is a member of the Board and co-founder of InnoCentive, Inc. He has been a strong advocate of open innovation and founded InnoCentive, Inc., along with other ventures that create the advantages of open and networked organizational structures, including: YourEncore, Inc., Coalesix, Inc., Maaguzi, Inc., Indigo Biosystems, Seriosity, Chorus and Collaborative Drug Discovery, Inc.
He currently serves on the Board of Directors of Fast Track Systems, Inc., and Collaborative Drug Discovery, Inc.; the advisory boards of the Center for Collective Intelligence (MIT), Phase Forward, Inc., YourEncore, Inc. and Coalesix, Inc. and as a member of the board of trustees of the Bankinter Foundation in Madrid.
He has lectured extensively at both national and international events and serves as a Visiting Scholar at the National Center for Supercomputing Application at the University of Illinois at Champaign-Urbana. He is also the former chairman of the Board of Editors of the Research Technology Management Journal. Dr. Bingham was the recipient of the Economist’s Fourth Annual Innovation Summit “Business Process Award” for InnoCentive. He was also named as one of Project Management Institute’s “Power 50″ leaders in October 2005.
Dr. Bingham had over 25 years of experience with Eli Lilly and Company in pharmaceutical research and development, research acquisitions and collaborations, portfolio management and R&D strategic planning. Among others, he held positions as Managing Director of the Mont-Saint-Guibert Development Centre, executive director of project and portfolio management, vice-president of sourcing innovation, vice-president of e.Lilly and vice-president of R&D strategy.
During his career he was instrumental in creating and developing Eli Lilly’s portfolio management process as well as establishing the divisions of Research Acquisitions, the Office of Alliance Management and e.Lilly, a unit for business innovation.
Dr. Bingham received a B.S. in chemistry from Brigham Young University and a Ph.D. in organic chemistry from Stanford University.
Innovation Program Manager
Kevin is the Innovation Program Manager responsible for European Seeker clients. Managing Seeker accounts and also delivering ONRAMP trainings and consulting services enables Kevin to have a broad perspective of how the needs of Seeker clients can be balanced with those of the Solver community. As the first member of the InnoCentive European team, Kevin has been involved in setting up a concrete european presence for InnoCentive. Ph.D. studies in molecular microbiology at the University of Liverpool lead Kevin into postdoctoral research and then into industry where he migrated away from the lab bench and into business roles in Product Management & Strategic Marketing for QIAGEN, Amaxa & Lonza BioScience. Understanding diverse technologies and planing how they could be commercialized introduced Kevin to a range of analytical and problem-solving tools that he uses in his everyday work consulting with clients to transform problem systems into focussed challenges. Kevin lives in Germany & enjoys socializing, cricket and spending time with his family.
Director of Product Management
Steven leads Product Management and focuses on R&D and bringing new functionality to life. Prior to InnoCentive, Steven held product management roles at Sermo (acquired by WorldOne), VFA, Inc., eRoom Technology (acquired by Documentum and EMC), and MyHelpDesk.com (acquired by Support.com). He began his career doing technical support for a medical device start-up, where he answered “patient-on-the-table” calls from neurosurgeons. Steven received a B.S. in Electrical Engineering (cum laude) from Tufts University, and an MBA from Duke University where he was a Rollins Scholar.